Intelligent Cannabinoid Therapeutic Systems

The present inventive concept integrates water-soluble, powdered cannabinoid and/or terpene extracts with cutting-edge technologies like AI, IoT, blockchain, and advanced materials to create personalized, optimized, and connected therapeutic systems for cannabinoid-based treatments.

The original patent disclosed a water-soluble, powdered cannabinoid and/or terpene extract, but it lacked the ability to personalize dosing, track efficacy, and ensure supply chain integrity. The new inventive concept addresses these limitations by incorporating synergistic technologies to create a more powerful and connected system.

The present inventive concept encompasses a range of systems and methods that combine the powdered cannabinoid extract with advanced technologies. For instance, a blockchain-based patient profiling module can store and analyze patient data, while an AI-driven cannabinoid dosing algorithm can provide personalized treatment plans. IoT-enabled devices can monitor and optimize powder blending, and smart packaging systems can ensure product authenticity and track inventory. Furthermore, generative AI models can predict optimal cannabinoid ratios, and 3D-printed pharmaceutical dosage forms can be customized for individual patients.

The new inventive concept is novel and non-obvious because it integrates distinct technologies to create a holistic system that goes beyond the original patent's powdered extract. The synergistic combination of AI, IoT, blockchain, and advanced materials provides a new level of personalization, optimization, and connectivity in cannabinoid-based treatments.

Alternative embodiments of the inventive concept could include using different types of AI models, such as reinforcement learning or natural language processing, to optimize cannabinoid dosing. Other variations could involve incorporating additional sensors or wearables to track patient data, or using different blockchain platforms to ensure supply chain integrity.

The present inventive concept has significant commercial potential in the pharmaceutical, healthcare, and wellness industries. The ability to provide personalized, optimized, and connected therapeutic systems for cannabinoid-based treatments could revolutionize the way patients receive care and could open up new market opportunities for companies operating in these spaces.